Changeflow GovPing Pharma & Drug Safety Technetium Tc 99m Albumin Aggregated Injection ...
Routine Notice Amended Draft

Technetium Tc 99m Albumin Aggregated Injection Revision

Favicon for www.uspnf.com USP Compendial Notices
Published
Detected
Email

Summary

USP's Small Molecules 4 Expert Committee has issued a Notice of Intent to Revise the Technetium Tc 99m Albumin Aggregated Injection monograph due to a compliance concern with the Appearance acceptance criterion. Comments with supporting data prompted this action. The proposed revision is targeted for an August 1, 2026 official date and is expected to be published as a Revision Bulletin on July 31, 2026.

What changed

The Small Molecules 4 Expert Committee intends to revise the Technetium Tc 99m Albumin Aggregated Injection monograph based on stakeholder comments indicating the Appearance acceptance criterion presents a compliance concern. USP will incorporate the submitted comments as appropriate. The proposed revision will be published on July 31, 2026, as a Revision Bulletin with a Targeted Official Date of August 1, 2026.

No immediate action is required at this time since this is a notice of intent rather than a final revision. Affected parties should monitor for the July 31, 2026 publication of the proposed Revision Bulletin. Stakeholders with relevant data or compliance concerns related to the Appearance criterion may contact Brice Wagner at USP (brice.wagner@usp.org) before the publication date. The actual compliance impact will be assessed when the final revision becomes official.

Archived snapshot

Apr 3, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Technetium Tc 99m Albumin Aggregated Injection

Type of Posting: Notice of Intent to Revise
Posting Date: 02-Apr-2026
Targeted Official Date: 01-Aug-2026
Revision Vehicle: Revision Bulletin ****
Expert Committee: Small Molecules Therapeutic Area 4

In accordance with the Rules and Procedures of the Council of Experts, this is to provide notice that the Small Molecules 4 Expert Committee intends to revise the Technetium Tc 99m Albumin Aggregated Injection monograph.

Comments with supporting data were received that indicate the acceptance criterion for Appearance presents a compliance concern. USP intends to revise this monograph to incorporate the comments, as appropriate.

It is anticipated that the proposed revision will be published on July 31, 2026, as a Revision Bulletin pursuant to the Rules and Procedures.

Should you have any questions, please contact Brice Wagner, Scientist IV (brice.wagner@usp.org)

Named provisions

Appearance

Get daily alerts for USP Compendial Notices

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USP.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USP
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Healthcare providers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Manufacturing Pharmaceutical Quality Standards
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Compliance frameworks
GxP
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USP Compendial Notices publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.